» Articles » PMID: 37998763

Spread of ST274 Clone in Different Niches: Resistome, Virulome, and Phylogenetic Relationship

Overview
Specialty Pharmacology
Date 2023 Nov 24
PMID 37998763
Authors
Affiliations
Soon will be listed here.
Abstract

ST274 is an international epidemic high-risk clone, mostly associated with hospital settings and appears to colonize cystic fibrosis (CF) patients worldwide. To understand the relevant mechanisms for its success, the biological and genomic characteristics of 11 ST274- strains from clinical and non-clinical origins were analyzed. The extensively drug-resistant (XDR/DTR), the non-susceptible to at least one agent (modR), and the -truncated (by IS) strains showed a chronic infection phenotype characterized by loss of serotype-specific antigenicity and low motility. Furthermore, the XDR/DTR and modR strains presented low pigment production and biofilm formation, which were very high in the -truncated strain. Their whole genome sequences were compared with other 14 ST274- genomes available in the NCBI database, and certain associations have been primarily detected: and genes, serotype O:3, / genotype, group V of type IV pili, and pyoverdine locus class II. Other general molecular markers highlight the absence of and / genes and the presence of the same mutational pattern in genes involving two-component sensor-regulator systems PmrAB and CreBD, exotoxin A, quorum-sensing RhlI, beta-lactamase expression regulator AmpD, PBP1A, or FusA2 elongation factor G. The proportionated ST274- results could serve as the basis for more specific studies focused on better antibiotic stewardship and new therapeutic developments.

Citing Articles

High-risk clones harboring β-lactamases: 2024 update.

Flores-Vega V, Partida-Sanchez S, Ares M, Ortiz-Navarrete V, Rosales-Reyes R Heliyon. 2025; 11(1):e41540.

PMID: 39850428 PMC: 11754179. DOI: 10.1016/j.heliyon.2024.e41540.


Investigation of cefiderocol resistance prevalence and resistance mechanisms in carbapenem-resistant , Germany 2019-21.

Kocer K, Boutin S, Moll M, Nurjadi D JAC Antimicrob Resist. 2024; 6(6):dlae183.

PMID: 39582836 PMC: 11584512. DOI: 10.1093/jacamr/dlae183.


Genomic and phenotypic characterization of isolates from two Mexican cystic fibrosis attention centers.

Nunez-Garcia L, Feliciano-Guzman J, Mireles-Davalos C, Lopez-Santiz J, Ovando-Fonseca J, Becerril-Vargas E Microbiol Spectr. 2024; :e0110024.

PMID: 39440985 PMC: 11619361. DOI: 10.1128/spectrum.01100-24.


Impact of multidrug resistance on the virulence and fitness of Pseudomonas aeruginosa: a microbiological and clinical perspective.

Sendra E, Fernandez-Munoz A, Zamorano L, Oliver A, Horcajada J, Juan C Infection. 2024; 52(4):1235-1268.

PMID: 38954392 PMC: 11289218. DOI: 10.1007/s15010-024-02313-x.

References
1.
Ruiz-Roldan L, Rojo-Bezares B, Lozano C, Lopez M, Chichon G, Torres C . Occurrence of spp. in Raw Vegetables: Molecular and Phenotypical Analysis of Their Antimicrobial Resistance and Virulence-Related Traits. Int J Mol Sci. 2021; 22(23). PMC: 8657893. DOI: 10.3390/ijms222312626. View

2.
Winsor G, Van Rossum T, Lo R, Khaira B, Whiteside M, Hancock R . Pseudomonas Genome Database: facilitating user-friendly, comprehensive comparisons of microbial genomes. Nucleic Acids Res. 2008; 37(Database issue):D483-8. PMC: 2686508. DOI: 10.1093/nar/gkn861. View

3.
Kos V, Deraspe M, McLaughlin R, Whiteaker J, Roy P, Alm R . The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility. Antimicrob Agents Chemother. 2014; 59(1):427-36. PMC: 4291382. DOI: 10.1128/AAC.03954-14. View

4.
McMackin E, Djapgne L, Corley J, Yahr T . Fitting Pieces into the Puzzle of Type III Secretion System Gene Expression. J Bacteriol. 2019; 201(13). PMC: 6560140. DOI: 10.1128/JB.00209-19. View

5.
Malhotra S, Hayes Jr D, Wozniak D . Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface. Clin Microbiol Rev. 2019; 32(3). PMC: 6589863. DOI: 10.1128/CMR.00138-18. View